With regard to B-cell lymphomas, both of them have been tried in MCL and FL cell lines and were shown to downregulate Akt and/or mTOR activity [27, 28, 40, 49]. The gene discussed is AKT1; the disease is B-cell non-Hodgkin lymphoma.